About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Change of Company Name and ASX Code

May 24, 2019August 28, 2019

Click here to read more

Post navigation

2019 Annual General Meeting Results

Ashland Purchases Manufacturing Rights for VitalET and TPM

Related Posts

Avecho licenses TPM® for development of enhanced cancer drugs

May 22, 2023May 22, 2023

Phosphagenics Director and Founder Steps Down

July 9, 2015

2017 AGM Resuls

May 31, 2017

Recent Posts

MEDIA | Ausbiz
March 7, 2025
March 2025 | Investor Webinar
March 6, 2025
MEDIA | 180 Markets
March 5, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.